Financial Performance - The company's operating revenue for Q1 2022 was ¥404,787,086.21, representing a year-on-year increase of 15.03%[5] - The net profit attributable to shareholders was -¥2,270,778.97, a decline of 112.55% compared to the same period last year[5] - The net profit attributable to shareholders after deducting non-recurring gains and losses was -¥2,716,429.48, down 115.09% year-on-year[5] - Total revenue for Q1 2022 was CNY 404,787,086.21, an increase of 15.0% compared to CNY 351,885,123.73 in Q1 2021[19] - Operating profit for Q1 2022 was a loss of CNY 5,382,875.88, compared to a profit of CNY 18,669,754.87 in Q1 2021[20] - Net profit for Q1 2022 was a loss of CNY 2,308,457.45, down from a profit of CNY 18,097,932.32 in Q1 2021[20] Assets and Liabilities - The total assets at the end of the reporting period were ¥3,094,668,713.51, an increase of 7.66% from the end of the previous year[6] - Total assets increased to CNY 3,094,668,713.51 in Q1 2022 from CNY 2,874,411,725.19 in Q1 2021, reflecting a growth of 7.7%[17] - Total liabilities rose to CNY 1,733,727,945.44 in Q1 2022, compared to CNY 1,536,145,491.61 in Q1 2021, an increase of 12.9%[17] - Current liabilities totaled CNY 1,255,229,502.41 in Q1 2022, up from CNY 1,174,409,642.87 in Q1 2021, representing a growth of 6.9%[17] Cash Flow - The net cash flow from operating activities was ¥43,062,191.17, with no applicable year-on-year comparison[5] - In Q1 2022, the company reported cash inflows from operating activities of CNY 612,502,069.41, a significant increase of 72.0% compared to CNY 356,391,773.89 in Q1 2021[23] - The net cash flow from operating activities was CNY 43,062,191.17, recovering from a negative cash flow of CNY -6,887,433.71 in the same period last year[23] - Cash inflows from financing activities amounted to CNY 247,858,062.56, an increase from CNY 230,383,634.37 in Q1 2021, leading to a net cash flow from financing activities of CNY 126,448,266.25[24] Research and Development - Research and development expenses totaled ¥21,845,657.88, which accounted for 5.40% of operating revenue, an increase of 1.66 percentage points year-on-year[6] - Research and development expenses for Q1 2022 were CNY 21,845,657.88, an increase of 66.5% from CNY 13,138,381.36 in Q1 2021[20] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 10,452[10] - The company incurred share-based payment expenses of ¥20,410,000 due to the implementation of the equity incentive plan, impacting net profit[6] Strategic Initiatives - The company has approved plans to issue convertible bonds to unspecified investors, aiming to enhance its capital structure[13] - The company received notice from the Shanghai Stock Exchange regarding the acceptance of its application for issuing securities, indicating progress in its capital raising efforts[13] - The company is focusing on expanding its market presence and enhancing its product offerings through strategic investments and potential acquisitions[13] Inventory and Receivables - Inventory levels increased significantly to ¥1,051,517,429.54 from ¥847,848,847.60, reflecting a rise of about 24%[15] - The company reported accounts receivable of ¥204,736,674.74, down from ¥345,105,573.82, showing a decrease of approximately 40.6%[15] Other Financial Metrics - The weighted average return on net assets was -0.17%, a decrease of 2.10 percentage points compared to the previous year[6] - The company's cash and cash equivalents reached ¥389,704,282.35, up from ¥277,211,695.46, indicating a growth of approximately 40.45%[15] - The company’s long-term equity investments stood at ¥9,446,487.29, slightly down from ¥9,598,781.49[15] - The company’s trading financial assets decreased to ¥40,042,656.25 from ¥60,124,642.88, a decline of approximately 33.5%[15] - Deferred income tax assets increased to CNY 11,477,991.93 in Q1 2022 from CNY 6,988,156.06 in Q1 2021, a rise of 64.0%[17] - Employee compensation payments increased to CNY 23,433,544.82 from CNY 19,960,481.12 year-over-year[23]
芳源股份(688148) - 2022 Q1 - 季度财报